Advertisement

Pre-mRNA Missplicing as a Cause of Human Disease

  • Tatyana Novoyatleva
  • Yesheng Tang
  • Ilona Rafalska
  • Stefan Stamm
Part of the Progress in Molecular and Subcellular Biology book series (PMSB, volume 44)

Keywords

Alternative Splice Cystic Fibrosis Transmembrane Conductance Regulator Spinal Muscular Atrophy Familial Dysautonomia Exon Inclusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson SL, Qiu J, Rubin BY (2003) EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem Biophys Res Commun 310: 627-633CrossRefPubMedGoogle Scholar
  2. Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR., Chen X, Whitney M, Pollok B, Zhang M, Androphy E, Burghes AH (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10: 2841-2849CrossRefPubMedGoogle Scholar
  3. Asparuhova M, Kole R, Schumperli, D (2005) Antisense derivatives of U7 and other small nuclear RNAs as tools to modify pre-mRNA splicing patterns. Gene Ther Regulation 2: 321-349CrossRefGoogle Scholar
  4. Badano JL, Leitch CC, Ansley SJ, May-Simera H, Lawson S, Lewis RA, Beales PL, Dietz HC, Fisher S, Katsanis N (2006) Dissection of epistasis in oligogenic Bardet-Biedl syndrome. Nature 439: 326-330CrossRefPubMedGoogle Scholar
  5. Baudry D, Hamelin M, Cabanis MO, Fournet JC, Tournade MF, Sarnacki S, Junien C, Jeanpierre C (2000) WT1 splicing alterations in Wilms’ tumors. Clin Cancer Res 6: 3957-3965PubMedGoogle Scholar
  6. Ben-Shaul Y, Bergman H, Soreq H (2005) Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression. Bioinformatics 21: 1129-1137CrossRefPubMedGoogle Scholar
  7. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336CrossRefPubMedGoogle Scholar
  8. Brichta L, Hofmann Y, Hahnen E, Siebzehnrubl FA, Raschke H, Blumcke I, Eyupoglu IY, Wirth B (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12: 2481-2489CrossRefPubMedGoogle Scholar
  9. Carstens RP, McKeehan WL, Garcia-Blanco MA (1998) An intronic sequence ele-ment mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol Cell Biol 18: 2205-2217PubMedGoogle Scholar
  10. Cartegni L, Krainer AR (2002) Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30: 377-384CrossRefPubMedGoogle Scholar
  11. Cartegni L, Krainer AR (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 10: 120-5CrossRefPubMedGoogle Scholar
  12. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESE finder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571CrossRefPubMedGoogle Scholar
  13. Catania MV, Aronica E, Yankaya B, Troost D (2001) Increased expression of neu-ronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord. J Neurosci 21: RC148PubMedGoogle Scholar
  14. Celotto AM, Graveley BR (2001). Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spatially regulated. Genetics 159: 599-608PubMedGoogle Scholar
  15. Celotto AM, Graveley BR (2002) Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing. Rna 8: 718-724CrossRefPubMedGoogle Scholar
  16. Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A 98: 9808-9813CrossRefPubMedGoogle Scholar
  17. Chao H, Mansfield SG, Bartel RC, Hiriyanna S, Mitchell LG, Garcia-Blanco MA, Walsh CE (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9: 1015-9CrossRefPubMedGoogle Scholar
  18. Chen W, Kubota S, Teramoto T, Nishimura Y, Yonemoto K, Seyama Y (1998) Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5′ splice site at the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry 37: 4420-4428CrossRefPubMedGoogle Scholar
  19. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D’Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 95: 13103-13107CrossRefPubMedGoogle Scholar
  20. D’Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM-Y, Bird TD, Schellenberg GD (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 96: 5598-5603CrossRefPubMedGoogle Scholar
  21. Daoud R, Mies G, Smialowska A, Oláh L, Hossmann K, Stamm S (2002) Ischemia induces a translocation of the splicing factor tra2-beta1 and changes alternative splicing patterns in the brain. J Neurosci 22: 5889-5899PubMedGoogle Scholar
  22. De Meirleir L, Lissens W, Benelli C, Ponsot G, Desguerre I, Marsac C, Rodriguez D, Saudubray JM, Poggi F, Liebaers I (1994) Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh’s encephalomyelopathy. Pediatr Res 36: 707-712CrossRefPubMedGoogle Scholar
  23. Denicourt C, Kozak CA, Rassart E (2003) Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing. J Virol 77: 37-44CrossRefPubMedGoogle Scholar
  24. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17: 419-437CrossRefPubMedGoogle Scholar
  25. Fehlbaum P, Guihal C, Bracco L, Cochet O (2005) A microarray configuration to quantify expression levels and relative abundance of splice variants. Nucleic Acids Res 33: e47CrossRefPubMedGoogle Scholar
  26. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 98: 12614-12619CrossRefPubMedGoogle Scholar
  27. Fischer DC, Noack K, Runnebaum IB, Watermann DO, Kieback DG, Stamm S, Stickeler E (2004) Expression of splicing factors in human ovarian cancer. Oncol Rep 11: 1085-1090PubMedGoogle Scholar
  28. Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22: 535-546CrossRefPubMedGoogle Scholar
  29. Gavin AL, Ait-Azzouzene D, Ware CF, Nemazee D 2003 DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine. BAFF. J Biol Chem 278: 38220-38228CrossRefGoogle Scholar
  30. Ge K, Minhas F, Duhadaway J, Mao NC, Wilson D, Buccafusca R, Sakamuro D, Nelson P, Malkowicz SB, Tomaszewski J, Prendergast GC (2000) Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 86: 155-161CrossRefPubMedGoogle Scholar
  31. Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H, Riederer P, Moller HJ, Andreadis A, Henkel K, Stamm S (2006) The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer’s disease. J Neurochem 96: 635-644CrossRefPubMedGoogle Scholar
  32. Gu YH, Kodama H, Murata Y, Mochizuki D, Yanagawa Y, Ushijima H, Shiba T, Lee CC (2001) ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome. Am J Med Genet 99: 217-222CrossRefPubMedGoogle Scholar
  33. Gupta S, Zink D, Korn B, Vingron M, Haas SA (2004) Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing. BMC Genomics 5: 72CrossRefPubMedGoogle Scholar
  34. Hasegawa Y, Kawame H, Ida H, Ohashi T, Eto Y (1994) Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing. Hum Genet 93: 415-420CrossRefPubMedGoogle Scholar
  35. Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B (2000) Htra2-beta 1 stim-ulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A 97: 9618-9623CrossRefPubMedGoogle Scholar
  36. Hull J, Shackleton S, Harris A (1994) Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells. Hum Mol Genet 3: 1141-1146CrossRefPubMedGoogle Scholar
  37. Huntsman MM, Tran BV, Potkin SG, Bunney WE, Jr, Jones EG (1998) Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A 95: 15066-15071CrossRefPubMedGoogle Scholar
  38. Iijima M, Tabira T, Poorkaj P, Schellenberg GD, Trojanowski JQ, Lee VM, Schmidt ML, Takahashi K, Nabika T, Matsumoto T, Yamashita Y, Yoshioka S, Ishino H (1999) A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 10: 497-501PubMedCrossRefGoogle Scholar
  39. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, Yang YY, Darnell RB (2000) Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359-371CrossRefPubMedGoogle Scholar
  40. Jin Y, Dietz HC, Montgomery RA, Bell WR, McIntosh I, Coller B, Bray PF (1996) Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J Clin Invest 98: 1745-54CrossRefPubMedGoogle Scholar
  41. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144CrossRefPubMedGoogle Scholar
  42. Jumaa H, Wei G, Nielsen PJ (1999) Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol 9: 899-902CrossRefPubMedGoogle Scholar
  43. Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR (2004) Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res 14: 331-342CrossRefPubMedGoogle Scholar
  44. Kashima T, Manley JL (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34: 460-463CrossRefPubMedGoogle Scholar
  45. Kralovicova J, Houngninou-Molango S, Kramer A, Vorechovsky I (2004) Branch site haplotypes that control alternative splicing. Hum Mol Genet 13: 3189-3202CrossRefPubMedGoogle Scholar
  46. Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M (2001) Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate 46: 163-172CrossRefPubMedGoogle Scholar
  47. Lacerra G, Sierakowska H, Carestia C, Fucharoen S, Summerton J, Weller D, Kole R (2000) Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc Natl Acad Sci U S A 97: 9591-9596CrossRefPubMedGoogle Scholar
  48. Lan N, Howrey RP, Lee SW, Smith CA, Sullenger BA (1998) Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 280: 1593-1596CrossRefPubMedGoogle Scholar
  49. Lewis BP, Green RE, Brenner SE (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A 100: 189-192CrossRefPubMedGoogle Scholar
  50. Lin C, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589-602CrossRefPubMedGoogle Scholar
  51. Liu S, Asparuhova M, Brondani V, Ziekau I, Klimkait T, Schumperli D (2004) Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res 32: 3752-3759CrossRefPubMedGoogle Scholar
  52. Liu W, Qian C, Francke U (1997) Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 16: 328-329CrossRefPubMedGoogle Scholar
  53. Llewellyn DH, Scobie GA, Urquhart AJ, Whatley SD, Roberts AG, Harrison PR, Elder GH (1996) Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: a synonymous codon mutation at - 22 bp from the 5′ splice site causes skipping of exon 3. J Med Genet 33: 437-438CrossRefPubMedGoogle Scholar
  54. Lopez-Bigas N, Audita B, Ouzounis C, Parra G, Guigo R (2005) Are splicing muta-tions the most frequent cause of hereditary disease? FEBS Lett in pressGoogle Scholar
  55. Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF (2001) Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 61: 3212-3219PubMedGoogle Scholar
  56. Lunn MR, Root DE, Martino AM, Flaherty SP, Kelley BP, Coovert DD, Burghes AH, Man NT, Morris GE, Zhou J, Androphy EJ, Sumner CJ, Stockwell BR (2004) Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol 11: 1489-1493CrossRefPubMedGoogle Scholar
  57. Maniatis T, Reed R (2002) An extensive network of coupling among gene expres-sion machines. Nature 416: 499-506CrossRefPubMedGoogle Scholar
  58. Maniatis T, Tasic B (2002) Alternative pre-mRNA splicing and proteome expan-sion in metazoans. Nature 418: 236-243CrossRefPubMedGoogle Scholar
  59. Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, Morgan JE, Partridge TA, Wilton SD (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A 98: 42-47CrossRefPubMedGoogle Scholar
  60. Matern D, He M, Berry SA, Rinaldo P, Whitley CB, Madsen PP, van Calcar SC, Lussky RC, Andresen BS, Wolff JA, Vockley J (2003) Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong popula-tion by newborn screening using tandem mass spectrometry. Pediatrics 112: 74-78CrossRefPubMedGoogle Scholar
  61. Missler M, Sudhof TC (1998) Neurexins: three genes and 1001 products. Trends Genet 14: 20-26CrossRefPubMedGoogle Scholar
  62. Nakai K, Sakamoto H (1994) Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 141: 171-177CrossRefPubMedGoogle Scholar
  63. Nissim-Rafinia M, Kerem B (2002) Splicing regulation as a potential genetic modifier. Trends Genet 18: 123-127CrossRefPubMedGoogle Scholar
  64. Pagani F, Buratti E, Stuani C, Baralle FE (2003) Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol Chem 278: 26580-26588CrossRefPubMedGoogle Scholar
  65. Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou A, Doudounakis S, Casals T, Baralle FE (2003b) New type of disease causing mutations: the exam-ple of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet 12: 1111-1120CrossRefPubMedGoogle Scholar
  66. Pfeffer U, Fecarotta E, Castagnetta L, Vidali G (1993) Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res 53: 741-743PubMedGoogle Scholar
  67. Ploos van Amstel JK, Bergman AJ, van Beurden EA, Roijers JF, Peelen T, van den Berg IE, Poll-The BT, Kvittingen EA, Berger R (1996) Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship. Hum Genet 97: 51-59PubMedGoogle Scholar
  68. Rafalska I, Zhang Z, Benderska N, Wolff H, Hartmann AM, Brack-Werner R, Stamm S (2004) The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Hum Mol Genet 13: 1535-1549CrossRefPubMedGoogle Scholar
  69. Relogio A, Ben-Dov C, Baum M, Ruggiu M, Gemund C, Benes V, Darnell RB, Valcarcel J (2005) Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem 280: 4779-4784CrossRefPubMedGoogle Scholar
  70. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 64: 414-421CrossRefPubMedGoogle Scholar
  71. Rogers CS, Vanoye CG, Sullenger BA, George AL Jr (2002) Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J Clin Invest 110: 1783-1789PubMedGoogle Scholar
  72. Sanford JR, Gray NK, Beckmann K, Caceres JF (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18: 755-768CrossRefPubMedGoogle Scholar
  73. Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Meydan N, Roifman C, Howell PL, Bowen T, Weinberg KI, Schroeder ML et al (1995) Three new adeno-sine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet 4: 2081-2087CrossRefPubMedGoogle Scholar
  74. Sazani P, Kole R (2003) Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J Clin Invest 112: 481-486PubMedGoogle Scholar
  75. Shen WF, Detmer K, Simonitch-Eason TA, Lawrence HJ, Largman C (1991) Alternative splicing of the HOX 2.2 homeobox gene in human hematopoietic cells and murine embryonic and adult tissues. Nucleic Acids Res 19: 539-545CrossRefPubMedGoogle Scholar
  76. Singh NN, Androphy EJ, Singh RN (2004a) An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun 315: 381-388CrossRefPubMedGoogle Scholar
  77. Singh NN, Androphy EJ, Singh RN (2004b) In vivo selection reveals combinator-ial controls that define a critical exon in the spinal muscular atrophy genes. Rna 10: 1291-1305CrossRefPubMedGoogle Scholar
  78. Singh NN, Androphy EJ, Singh RN (2004c) The regulation and regulatory activities of alternative splicing of the SMN gene.Crit Rev Eukary Gene Exp 14: in pressGoogle Scholar
  79. Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci U S A 100: 4114-4119CrossRefPubMedGoogle Scholar
  80. Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13: 429-436CrossRefPubMedGoogle Scholar
  81. Smith CW, Valcarcel J (2000) Alternative pre-mRNA splicing: the logic of combi-natorial control. Trends Biochem Sci 25: 381-388CrossRefPubMedGoogle Scholar
  82. Soret J, Bakkour N, Maire S, Durand S, Zekri L, Gabut M, Fic W, Divita G, Rivalle C, Dauzonne D, Nguyen C-H, Jeanteur P, Tazi J (2005) Selective modi-fication of alternative splicing by indole derivatives that target SR protein splicing factors. Proc Natl Acad Sci U S A, in pressGoogle Scholar
  83. Stamm S (2002) Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum Mol Genet 11: 2409-2416CrossRefPubMedGoogle Scholar
  84. Stamm S, Zhu J, Nakai K, Stoilov P, Stoss O Zhang MQ (2000) An alternative-exon database and its statistical analysis. DNA Cell Biol 19: 739-756CrossRefPubMedGoogle Scholar
  85. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA, Soreq H (2005) Function of alternative splicing. Gene 344C: 1-20CrossRefGoogle Scholar
  86. Steinman HA, Burstein E, Lengner C, Gosselin J, Pihan G, Duckett CS, Jones SN (2004) An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J Biol Chem 279: 4877-4886CrossRefPubMedGoogle Scholar
  87. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21: 577-581CrossRefPubMedGoogle Scholar
  88. Stoilov P, Meshorer E, Gencheva M, Glick D, Soreq H, Stamm S (2002) Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol 21: 803-818CrossRefPubMedGoogle Scholar
  89. Thanaraj TA, Stamm S, Clark F, Riethoven JJ, Le Texier V, Muilu J (2004) ASD: the Alternative Splicing Database. Nucleic Acids Res 32:Database issue D 64-69Google Scholar
  90. Umeda Y, Taniguchi S, Arima K, Piao YS, Takahashi H, Iwatsubo T, Mann D, Hasegawa M (2004) Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci Lett 359: 151-154CrossRefPubMedGoogle Scholar
  91. Vawter MP, Frye MA, Hemperly JJ, VanderPutten DM, Usen N, Doherty P, Saffell JL, Issa F, Post RM, Wyatt RJ, Freed WJ (2000) Elevated concentration of N-CAM VASE isoforms in schizophrenia. J Psychiatr Res 34: 25-34CrossRefPubMedGoogle Scholar
  92. Venables JP, Elliott DJ, Makarova OV, Makarov EM, Cooke HJ, Eperon IC (2000) RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. Hum Mol Genet 9: 685-694CrossRefPubMedGoogle Scholar
  93. Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, Al-Maghtheh M, Ebenezer ND, Willis C, Moore AT, Bird AC, Hunt DM, Bhattacharya SS (2001) A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell 8: 375-381CrossRefPubMedGoogle Scholar
  94. Wang HY, Xu X, Ding JH, Bermingham JR Jr, Fu XD (2001) SC35 plays a role in T cell development and alternative splicing of CD45. Mol Cell 7: 331-342CrossRefPubMedGoogle Scholar
  95. Watanabe T, Sullenger BA (2000) Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc Natl Acad Sci U S A 97: 8490-8494CrossRefPubMedGoogle Scholar
  96. Xavier KA, Eder PS, Giordano T (2000) RNA as a drug target: methods for biophysical characterization and screening. Trends Biotechnol 18: 349-356CrossRefPubMedGoogle Scholar
  97. Xu Q, Lee C (2003) Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 31: 5635-5643CrossRefPubMedGoogle Scholar
  98. Xu X, Yang D, Ding JH, Wang W, Chu PH, Dalton ND, Wang HY, Bermingham JR Jr, Ye Z, Liu F, Rosenfeld MG, Manley JL, Ross J Jr, Chen J, Xiao RP, Cheng H, Fu XD (2005) ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120: 59-72CrossRefPubMedGoogle Scholar
  99. Yang JH, Nie Y, Zhao Q, Su Y, Pypaert M, Su H, Rabinovici R (2003) Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J Biol Chem 278: 45833-45842CrossRefPubMedGoogle Scholar
  100. Zavadakova P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V, Zavad’akova P (2002) CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis 25: 461-476CrossRefPubMedGoogle Scholar
  101. Zavadakova P, Fowler B, Suormala T, Novotna Z, Mueller P, Hennermann JB, Zeman J, Vilaseca MA, Vilarinho L, Gutsche S, Wilichowski E, Horneff G, Kozich V (2005) cblE type of homocystinuria due to methionine synthase reduc-tase deficiency: functional correction by minigene expression. Hum Mutat 25: 239-247CrossRefPubMedGoogle Scholar
  102. Zhang ML, Lorson CL, Androphy EJ, Zhou J (2001) An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther 8: 1532-1538CrossRefPubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2006

Authors and Affiliations

  • Tatyana Novoyatleva
    • 1
  • Yesheng Tang
    • 1
  • Ilona Rafalska
    • 1
  • Stefan Stamm
    • 1
  1. 1.Institute for BiochemistryUniversity of ErlangenGermany

Personalised recommendations